End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.1 TWD | -1.83% | +0.31% | -18.48% |
Apr. 25 | USI's Q1 Profit Rises 21%, Operating Income Jumps 4% | MT |
Mar. 15 | USI Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.4 times its sales.
- The company appears to be poorly valued given its net asset value.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.48% | 534M | - | ||
+7.42% | 41.43B | B- | ||
-22.95% | 21.34B | B- | ||
-14.90% | 13.28B | B- | ||
-9.63% | 10.19B | B+ | ||
+21.44% | 8.51B | C+ | ||
+9.02% | 6.81B | C+ | ||
-28.46% | 5.44B | C | ||
-23.37% | 3.66B | B+ | ||
-21.29% | 3.42B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1304 Stock
- Ratings USI Corporation